EMG
XENT

Ellington Management Group’s Intersect ENT, Inc XENT Stock Holding History

Ellington Management Group’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,300
Closed -$177K – 974
2017
Q1 		$177K Buy
+10,300
New +$144K 0.01% 606

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Ellington Management Group's XENT Position: Q2 2017 in Review

Ellington Management Group sold out of Intersect ENT, Inc (XENT) in Q2 2017, closing a stake of 10,300 shares — an estimated $177K sold.

Ellington Management Group first reported a position in XENT in Q1 2017 and held it in 1 quarter. The position peaked at $177K in Q1 2017. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2017.

  • Ellington Management Group reported no remaining Intersect ENT, Inc position as of Q2 2017 after selling out during the quarter.
  • Ellington Management Group sold 10,300 Intersect ENT, Inc shares in Q2 2017, an estimated $177K.
  • Ellington Management Group first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 1 quarter.
  • Ellington Management Group's Intersect ENT, Inc position peaked at $177K in Q1 2017.
  • 128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2017.

Based on Ellington Management Group's 13F filing for Q2 2017, filed 14 Aug 2017.